Vertex Pharmaceuticals (VRTX)
(Delayed Data from NSDQ)
$462.88 USD
-0.27 (-0.06%)
Updated Sep 27, 2024 04:00 PM ET
After-Market: $462.85 -0.03 (-0.01%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$462.88 USD
-0.27 (-0.06%)
Updated Sep 27, 2024 04:00 PM ET
After-Market: $462.85 -0.03 (-0.01%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Zacks News
5 Strong Buy Growth Stocks for this Secular Bull Rally
by Tracey Ryniec
How can the stock market be near another all-time high with a pandemic and 40 million unemployed? Secular bull markets don't care about headlines.
Zacks.com featured highlights include: Vertex Pharmaceuticals, Dollar General, CVS Health and Tractor Supply
by Zacks Equity Research
Zacks.com featured highlights include: Vertex Pharmaceuticals, Dollar General, CVS Health and Tractor Supply
4 Stocks That Flaunt an Impressive Interest Coverage Ratio
by Sumit Singh
Interest coverage ratio is used to determine how effectively a company can pay the interest charged on its debt.
3 Strong Pharmaceutical and Biotech Stocks to Buy for Coronavirus Immunity
by Benjamin Rains
Let's dive into three large-cap pharmaceutical and biotech stocks that appear set to grow during the pandemic-induced downturn and the eventual recovery...
Why Is Vertex (VRTX) Up 10.4% Since Last Earnings Report?
by Zacks Equity Research
Vertex (VRTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks.com featured highlights include: BJs Wholesale Club, Fortinet, Vertex Pharmaceuticals, SPS Commerce and Repligen
by Zacks Equity Research
Zacks.com featured highlights include: BJs Wholesale Club, Fortinet, Vertex Pharmaceuticals, SPS Commerce and Repligen
VRTX vs. ILMN: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
VRTX vs. ILMN: Which Stock Is the Better Value Option?
Has Vertex Pharmaceuticals (VRTX) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (VRTX) Outperforming Other Medical Stocks This Year?
Profit From 5 Stocks Likely to Beat on Earnings
by Sanghamitra Saha
Bet on five stocks that are likely to outdo earnings estimates.
S&P Reclaims 3,000: Buy 6 Stocks With More Than 25% Growth
by Sweta Killa
In the latest market rally driven by hopes surrounding potential coronavirus vaccines and reopening of the economy, the S&P 500 reclaimed its 3,000 level and is poised to rise further.
2 Top Factors Buoy Wall Street Since Memorial Day: 5 Picks
by Tirthankar Chakraborty
As optimism surrounding a coronavirus vaccine and consumer activity begin to pick up, Wall Street is expected to trade higher.
Dr. Reddy's (RDY) Q4 Earnings Increase Y/Y, Revenues Beat
by Zacks Equity Research
Dr. Reddy's (RDY) fourth-quarter earnings and sales increase year over year.
The Zacks Analyst Blog Highlights: Chegg, Quidel, MarketAxess, Dropbox and Vertex Pharmaceuticals
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Chegg, Quidel, MarketAxess, Dropbox and Vertex Pharmaceuticals
The Zacks Analyst Blog Highlights: Chegg, Nautilus Group, Sprouts Farmers Market, VeriSign and Vertex Pharmaceuticals
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Chegg, Nautilus Group, Sprouts Farmers Market, VeriSign and Vertex Pharmaceuticals
The Zacks Analyst Blog Highlights: The Hain Celestial Group, Murphy USA, Vertex Pharmaceuticals, Sprouts Farmers Market and ASE Technology
by Zacks Equity Research
The Zacks Analyst Blog Highlights: The Hain Celestial Group, Murphy USA, Vertex Pharmaceuticals, Sprouts Farmers Market and ASE Technology
Vertex Pharmaceuticals, Align Technology, Walmart, Home Depot and Target highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Vertex Pharmaceuticals, Align Technology, Walmart, Home Depot and Target highlighted as Zacks Bull and Bear of the Day
5 Reasons Why Growth Stocks Will Soar Further
by Sanghamitra Saha
A few positive developments on the vaccine front, unprecedented economic help, reopening of economies and some bullish economic datapoints should facilitate growth stocks ahead.
Major Indexes Defying "Sell in May" Adage: 5 Growth Picks
by Nalak Das
Half of this month is already over, yet Wall Street is in green defying the well-known financial-world adage "Sell in May and go away."
Bull of the Day: Vertex Pharma (VRTX)
by Kevin Cook
While COVID-19 interrupts clinical trials, the champ of cystic fibrosis is about to repeat another year of 37% revenue growth
Surging Earnings Estimates Signal Good News for Vertex Pharmaceuticals (VRTX)
by Zacks Equity Research
Vertex Pharmaceuticals (VRTX) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.
Wall Street to Rally as Powell Talks Recovery: 5 Big Winners
by Tirthankar Chakraborty
Wall Street poised to gain after Powell expressed confidence that the U.S. economy will recover beginning summer.
Buy These 4 Stocks With Attractive Interest Coverage Ratio
by Sumit Singh
Interest Coverage Ratio is used to determine how effectively a company can pay the interest charges on its debt.
3 Reasons Growth Investors Will Love Vertex (VRTX)
by Zacks Equity Research
Vertex (VRTX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Has Vertex Pharmaceuticals (VRTX) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (VRTX) Outperforming Other Medical Stocks This Year?
Wall Street Resilient to Crisis-Era Jobless Rate: 5 Picks
by Tirthankar Chakraborty
Stocks finished last week in the green despite massive job losses as the market expects a sharp but short recession.